Top

Tag: clinical trials


Industry Focus Areas, Medical

Update on overseas clinical trials progress of novel adjuvant COVID-19 vaccine ReCOV

November 8, 2022

Via: PR Newswire

Jiangsu Recbio Technology Co., Ltd. (the “Company”, together with its subsidiaries, the “Group”) is pleased to announce that positive results were achieved for its primary vaccination Phase II study in the Philippines and heterologous booster vaccination Phase II study in […]


Industry Focus Areas, Medical

FDA rejects Verily filing for wrist-worn Parkinson’s clinical trial device

June 14, 2021

Via: MedTech Dive

In recent years, FDA has cleared Verily’s Study Watch for use as an electrocardiogram and as an irregular pulse monitor via its 510(k) pathway. Verily followed up by filing to use the device as a drug development tool for Parkinson’s […]


Industry Focus Areas, Medical

Cellect Biotechnology launches U.S. clinical trial

February 5, 2019

Via: Mass Device

Cellect Biotechnology (NSDQ:APOP) said it is collaborating with Washington University on a study of its ApoGraft stem cell selection technology for bone marrow transplantations. This will be the first clinical trial in the U.S. using Tel Aviv, Israel-based Cellect’s ApoGraft, […]


Industry Focus Areas, Medical

Inovio touts intradermal delivery of HIV vaccine

October 26, 2018

Via: Mass Device

Inovio Pharmaceuticals (NSDQ:INO) reported today that its synthetic HIV vaccine, Pennvax-GP, demonstrated durable antibody and T cell immune responses throughout a Phase I trial. The company found that Pennvax-GP plasmids delivered intradermally with Inovio’s Cellectra device triggered equivalent or superior […]


Industry Focus Areas, Medical

Medtronic launches one-month DAPT study for drug-eluting stent in U.S., Japan

September 10, 2018

Via: Mass Device

Medtronic (NYSE:MDT) said today that it’s launching a study in the U.S. and Japan to evaluate dual antiplatelet therapy in high bleeding risk patients implanted with the Resolute Onyx drug-eluting stent during percutaneous coronary intervention. The company’s Onyx One Clear […]


Industry Focus Areas, Medical

Medtronic launches Extravascular ICD pilot study

August 10, 2018

Via: Mass Device

Medtronic (NYSE:MDT) said yesterday it launched a pilot study of its investigational Extravascular Implantable cardioverter defibrillator system, with the first patient implant already performed at New Zealand’s Christchurch Hospital. The Fridley, Minn.-based company’s EV ICD system uses leads placed outside […]


Industry Focus Areas, Medical

Nanobiotix inks $47m financing to support nanomedicine development

July 30, 2018

Via: Mass Device

Nanobiotix (PAR:NANO.PA) inked a non-dilutive financial deal with the European Investment Bank last week to support the development of its nanoparticle-based cancer therapies. The Paris, France-based company said it landed a five-year loan to borrow up to €40 million ($46.7 […]


Industry Focus Areas, Medical

FDA approves ReCor Medical’s pivotal ultrasound denervation study

July 5, 2018

Via: Mass Device

ReCor Medical said this week that the FDA approved a new pivotal study of the company’s Paradise ultrasound denervation system for the treatment of hypertension. The Palo Alto, Calif.-based company reported that its trial, Radiance-II, will be a randomized, sham-controlled […]


Industry Focus Areas, Medical

J&J touts perioperative efficiency CareAdvantage study data

October 5, 2017

Via: Mass Device

Johnson & Johnson (NYSE:JNJ) this week reported results from a real-world evidence study of its CareAdvantage program, touting improved tray set up time and reduced surgical tray numbers with an estimated $262,000 saved annually. The data was presented at the […]


Industry Focus Areas, Medical

Thync touts first effective use of bioelectronics to treat psoriasis

October 4, 2017

Via: Mass Device

Bioelectronics company Thync touted positive results today from the pilot study of its neuromodulation technology as a treatment for plaque psoriasis. The study showed that people using Thync’s technology experienced reduced redness, scaling and itchiness of their plaque psoriasis after […]


Industry Focus Areas, Medical, Regulations

Following regulatory win, GSK & Innoviva tout data for once-daily triple-med inhaler

September 20, 2017

Via: Mass Device

GlaxoSmithKline (NYSE:GSK) and Innoviva (NSDQ:INVA) notched a win this week after the FDA approved its once-daily, triple combination therapy for the treatment of chronic obstructive pulmonary disease. Last week, an EU agency recommended the inhaler’s approval. Now, the companies are […]


Industry Focus Areas, Medical

Intact Vascular wins CE Mark for Tack blood vessel repair device

January 18, 2017

Via: Mass Device

Intact Vascular said today that it won CE Mark approval in the European Union for its Tack endovascular system to repair arterial dissections after percutaneous transluminal angioplasty below the knee. The indication extends the system’s use in the EU to the tibial arteries between […]